valine has been researched along with mitoxantrone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kreuzer, KN; O'Reilly, EK | 1 |
Ban, M; Compston, A; Dubois, B; Goris, A; Gray, J; Maranian, M; Sawcer, S; Walton, A; Yeo, TW | 1 |
1 trial(s) available for valine and mitoxantrone
Article | Year |
---|---|
CD24 Ala/Val polymorphism and multiple sclerosis.
Topics: Alanine; CD24 Antigen; Chemotaxis, Leukocyte; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Polymorphism, Single Nucleotide; Receptors, Chemokine; Valine | 2006 |
1 other study(ies) available for valine and mitoxantrone
Article | Year |
---|---|
A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amsacrine; Antineoplastic Agents; Bacteriophage T4; Binding Sites; DNA Damage; DNA Topoisomerases, Type II; DNA, Superhelical; Ellipticines; Enzyme Inhibitors; Filtration; Glycine; Mitoxantrone; Molecular Sequence Data; Oxolinic Acid; Podophyllotoxin; Point Mutation; Topoisomerase II Inhibitors; Valine | 2002 |